

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | detection of visible light (GO:0009584) | 9.78932335 |
| 2 | positive regulation of guanylate cyclase activity (GO:0031284) | 9.74177609 |
| 3 | regulation of guanylate cyclase activity (GO:0031282) | 8.81239347 |
| 4 | * visual perception (GO:0007601) | 8.63740643 |
| 5 | * sensory perception of light stimulus (GO:0050953) | 8.54728714 |
| 6 | protein-chromophore linkage (GO:0018298) | 7.95421292 |
| 7 | cellular response to light stimulus (GO:0071482) | 7.45802715 |
| 8 | detection of external stimulus (GO:0009581) | 6.99759393 |
| 9 | retina development in camera-type eye (GO:0060041) | 6.90851004 |
| 10 | detection of abiotic stimulus (GO:0009582) | 6.86308542 |
| 11 | regulation of cGMP metabolic process (GO:0030823) | 6.50850061 |
| 12 | positive regulation of cGMP biosynthetic process (GO:0030828) | 5.89720606 |
| 13 | regulation of cGMP biosynthetic process (GO:0030826) | 5.54283724 |
| 14 | axon ensheathment in central nervous system (GO:0032291) | 5.22635271 |
| 15 | central nervous system myelination (GO:0022010) | 5.22635271 |
| 16 | positive regulation of cGMP metabolic process (GO:0030825) | 5.19186929 |
| 17 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 5.13672812 |
| 18 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 5.00321646 |
| 19 | nonmotile primary cilium assembly (GO:0035058) | 4.97579446 |
| 20 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 4.91597099 |
| 21 | cell morphogenesis involved in neuron differentiation (GO:0048667) | 4.78576083 |
| 22 | cellular response to radiation (GO:0071478) | 4.78075582 |
| 23 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 4.60431645 |
| 24 | astrocyte development (GO:0014002) | 4.57427260 |
| 25 | glutamate secretion (GO:0014047) | 4.56698980 |
| 26 | synaptic vesicle exocytosis (GO:0016079) | 4.56579854 |
| 27 | cellular response to electrical stimulus (GO:0071257) | 4.54252326 |
| 28 | vitamin A metabolic process (GO:0006776) | 4.44749755 |
| 29 | adaptation of signaling pathway (GO:0023058) | 4.29118204 |
| 30 | regulation of G-protein coupled receptor protein signaling pathway (GO:0008277) | 4.23838838 |
| 31 | regulation of voltage-gated calcium channel activity (GO:1901385) | 4.23744715 |
| 32 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.10713978 |
| 33 | * sensory perception (GO:0007600) | 4.03031762 |
| 34 | postsynaptic membrane organization (GO:0001941) | 4.02664238 |
| 35 | response to parathyroid hormone (GO:0071107) | 4.01541120 |
| 36 | L-amino acid import (GO:0043092) | 3.97852774 |
| 37 | protein prenylation (GO:0018342) | 3.93413382 |
| 38 | prenylation (GO:0097354) | 3.93413382 |
| 39 | negative regulation of catenin import into nucleus (GO:0035414) | 3.87567451 |
| 40 | response to light stimulus (GO:0009416) | 3.86643860 |
| 41 | astrocyte differentiation (GO:0048708) | 3.85416380 |
| 42 | neuron development (GO:0048666) | 3.82362301 |
| 43 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.79600964 |
| 44 | retina homeostasis (GO:0001895) | 3.70655009 |
| 45 | positive regulation of synapse maturation (GO:0090129) | 3.65416054 |
| 46 | adenosine receptor signaling pathway (GO:0001973) | 3.63787153 |
| 47 | retina layer formation (GO:0010842) | 3.55634363 |
| 48 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 3.55230789 |
| 49 | amino acid import (GO:0043090) | 3.52450368 |
| 50 | neuronal ion channel clustering (GO:0045161) | 3.50188598 |
| 51 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 3.49823475 |
| 52 | estrogen biosynthetic process (GO:0006703) | 3.49416107 |
| 53 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.46031524 |
| 54 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.46031524 |
| 55 | short-term memory (GO:0007614) | 3.41744960 |
| 56 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.41243314 |
| 57 | cellular response to nitric oxide (GO:0071732) | 3.38975074 |
| 58 | protein localization to synapse (GO:0035418) | 3.38704229 |
| 59 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 3.35494092 |
| 60 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.34374865 |
| 61 | * photoreceptor cell differentiation (GO:0046530) | 3.33913522 |
| 62 | * eye photoreceptor cell differentiation (GO:0001754) | 3.33913522 |
| 63 | behavioral response to ethanol (GO:0048149) | 3.32562773 |
| 64 | regulation of penile erection (GO:0060405) | 3.31347999 |
| 65 | potassium ion import (GO:0010107) | 3.30782451 |
| 66 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.19478305 |
| 67 | chemosensory behavior (GO:0007635) | 3.17491759 |
| 68 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.17309097 |
| 69 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.12803023 |
| 70 | response to histamine (GO:0034776) | 3.10757576 |
| 71 | cellular sodium ion homeostasis (GO:0006883) | 3.10016265 |
| 72 | locomotory exploration behavior (GO:0035641) | 3.09922401 |
| 73 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.07913640 |
| 74 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.07081769 |
| 75 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.00559323 |
| 76 | neurotransmitter secretion (GO:0007269) | 3.00392606 |
| 77 | acidic amino acid transport (GO:0015800) | 3.00140628 |
| 78 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.98396575 |
| 79 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.97566739 |
| 80 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.97566739 |
| 81 | myelin maintenance (GO:0043217) | 2.97474185 |
| 82 | cerebellar granule cell differentiation (GO:0021707) | 2.97036474 |
| 83 | membrane hyperpolarization (GO:0060081) | 2.95815128 |
| 84 | regulation of synaptic vesicle transport (GO:1902803) | 2.94985219 |
| 85 | negative regulation of telomerase activity (GO:0051974) | 2.94418743 |
| 86 | positive regulation of neurotransmitter transport (GO:0051590) | 2.90681404 |
| 87 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.90514545 |
| 88 | regulation of response to food (GO:0032095) | 2.89696299 |
| 89 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.88580674 |
| 90 | cerebellar Purkinje cell layer development (GO:0021680) | 2.87224514 |
| 91 | cellular potassium ion homeostasis (GO:0030007) | 2.85681063 |
| 92 | negative regulation of DNA biosynthetic process (GO:2000279) | 2.85074415 |
| 93 | regulation of synapse structural plasticity (GO:0051823) | 2.84861874 |
| 94 | L-glutamate transport (GO:0015813) | 2.83273331 |
| 95 | cellular response to cadmium ion (GO:0071276) | 2.81356616 |
| 96 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 2.80613653 |
| 97 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.79001409 |
| 98 | regulation of synaptic plasticity (GO:0048167) | 2.78546300 |
| 99 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.78347910 |
| 100 | white fat cell differentiation (GO:0050872) | 2.77916239 |
| 101 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.77325221 |
| 102 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.75834455 |
| 103 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.75834455 |
| 104 | response to leptin (GO:0044321) | 2.75230991 |
| 105 | arachidonic acid secretion (GO:0050482) | 2.74712499 |
| 106 | icosanoid secretion (GO:0032309) | 2.74712499 |
| 107 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.74654791 |
| 108 | synaptic vesicle maturation (GO:0016188) | 2.74542175 |
| 109 | retinoid metabolic process (GO:0001523) | 2.73568221 |
| 110 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.73121516 |
| 111 | axoneme assembly (GO:0035082) | 2.72221128 |
| 112 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.72159680 |
| 113 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.71582305 |
| 114 | negative regulation of cation channel activity (GO:2001258) | 2.71449038 |
| 115 | regulation of sensory perception (GO:0051931) | 2.69842925 |
| 116 | regulation of sensory perception of pain (GO:0051930) | 2.69842925 |
| 117 | protein heterotetramerization (GO:0051290) | 2.69793171 |
| 118 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.68987787 |
| 119 | neuronal action potential propagation (GO:0019227) | 2.68380403 |
| 120 | regulation of synapse maturation (GO:0090128) | 2.67281064 |
| 121 | response to radiation (GO:0009314) | 2.64656527 |
| 122 | axon ensheathment (GO:0008366) | 2.64639557 |
| 123 | ensheathment of neurons (GO:0007272) | 2.64639557 |
| 124 | positive regulation of protein dephosphorylation (GO:0035307) | 2.64530396 |
| 125 | neuron projection regeneration (GO:0031102) | 2.63809099 |
| 126 | cell migration involved in heart development (GO:0060973) | 2.61897597 |
| 127 | sodium ion export (GO:0071436) | 2.61297243 |
| 128 | regulation of plasminogen activation (GO:0010755) | 2.61269017 |
| 129 | behavioral fear response (GO:0001662) | 2.60946181 |
| 130 | behavioral defense response (GO:0002209) | 2.60946181 |
| 131 | positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745) | 2.60662338 |
| 132 | lipid translocation (GO:0034204) | 2.60495779 |
| 133 | phospholipid translocation (GO:0045332) | 2.60495779 |
| 134 | regulation of respiratory system process (GO:0044065) | 2.60411997 |
| 135 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.59803263 |
| 136 | myelination (GO:0042552) | 2.58752702 |
| 137 | lipoprotein transport (GO:0042953) | 2.58033628 |
| 138 | retinol metabolic process (GO:0042572) | 2.57661516 |
| 139 | positive regulation of extracellular matrix organization (GO:1903055) | 2.57063852 |
| 140 | long-term synaptic potentiation (GO:0060291) | 2.56950706 |
| 141 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.56619081 |
| 142 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.56429705 |
| 143 | dopamine receptor signaling pathway (GO:0007212) | 2.56370832 |
| 144 | behavioral response to cocaine (GO:0048148) | 2.56283312 |
| 145 | neuron cell-cell adhesion (GO:0007158) | 2.55942875 |
| 146 | detection of temperature stimulus (GO:0016048) | 2.55322553 |
| 147 | neuromuscular process controlling balance (GO:0050885) | 2.53862520 |
| 148 | synaptic transmission, dopaminergic (GO:0001963) | 2.53825414 |
| 149 | diterpenoid metabolic process (GO:0016101) | 2.52574807 |
| 150 | detection of chemical stimulus involved in sensory perception (GO:0050907) | 2.52009896 |
| 151 | dicarboxylic acid transport (GO:0006835) | 2.51480774 |
| 152 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 2.49966973 |
| 153 | layer formation in cerebral cortex (GO:0021819) | 2.48451337 |
| 154 | cellular response to reactive nitrogen species (GO:1902170) | 2.48228220 |
| 155 | potassium ion homeostasis (GO:0055075) | 2.48065715 |
| 156 | exploration behavior (GO:0035640) | 2.47547123 |
| 157 | response to pheromone (GO:0019236) | 2.47384397 |
| 158 | one-carbon compound transport (GO:0019755) | 2.45885183 |
| 159 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.45645382 |
| 160 | cell communication by electrical coupling (GO:0010644) | 2.44900151 |
| 161 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.43940297 |
| 162 | barbed-end actin filament capping (GO:0051016) | 2.42882790 |
| 163 | substantia nigra development (GO:0021762) | 2.41118548 |
| 164 | positive regulation of dendritic spine development (GO:0060999) | 2.40835964 |
| 165 | neuromuscular process controlling posture (GO:0050884) | 2.40534987 |
| 166 | cellular response to abiotic stimulus (GO:0071214) | 2.40211816 |
| 167 | positive regulation of cyclase activity (GO:0031281) | 2.40071793 |
| 168 | regulation of neurotransmitter uptake (GO:0051580) | 2.38341914 |
| 169 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 2.37743643 |
| 170 | terpenoid metabolic process (GO:0006721) | 2.30670622 |
| 171 | positive regulation of membrane potential (GO:0045838) | 2.28652942 |
| 172 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.28018030 |
| 173 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 17.9498341 |
| 174 | rhodopsin mediated signaling pathway (GO:0016056) | 17.4857110 |
| 175 | retinal cone cell development (GO:0046549) | 15.1575151 |
| 176 | photoreceptor cell development (GO:0042461) | 12.8359172 |
| 177 | eye photoreceptor cell development (GO:0042462) | 12.2381878 |
| 178 | photoreceptor cell maintenance (GO:0045494) | 12.0980137 |
| 179 | detection of light stimulus involved in sensory perception (GO:0050962) | 11.2269737 |
| 180 | detection of light stimulus involved in visual perception (GO:0050908) | 11.2269737 |
| 181 | retinal rod cell development (GO:0046548) | 10.7319662 |
| 182 | phototransduction (GO:0007602) | 10.4520318 |
| 183 | GMP metabolic process (GO:0046037) | 10.4154231 |
| 184 | phototransduction, visible light (GO:0007603) | 10.1574291 |
| 185 | detection of light stimulus (GO:0009583) | 10.0154037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.78666457 |
| 2 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 4.48869619 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 4.25896688 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.90833838 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 3.39827491 |
| 6 | VDR_22108803_ChIP-Seq_LS180_Human | 3.39734033 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 3.03319695 |
| 8 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 2.94324218 |
| 9 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.71018569 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.41196204 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.31447094 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23216511 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.14194714 |
| 14 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.13635907 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.11840471 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.09077373 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.06723169 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.89311300 |
| 19 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.87260220 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.86345736 |
| 21 | KDM2B_26808549_Chip-Seq_K562_Human | 1.82764474 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.81807278 |
| 23 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.81658271 |
| 24 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.77940342 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.77590419 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.74279086 |
| 27 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.72254202 |
| 28 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.71230810 |
| 29 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.67939817 |
| 30 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.65594925 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.65248532 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.60962121 |
| 33 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.60818463 |
| 34 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.60661641 |
| 35 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.60030669 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59473213 |
| 37 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.57412020 |
| 38 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.56422332 |
| 39 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.56401510 |
| 40 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55947928 |
| 41 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.55425914 |
| 42 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.53195410 |
| 43 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.51896212 |
| 44 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.51625281 |
| 45 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.51386158 |
| 46 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 1.51223343 |
| 47 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.50236323 |
| 48 | AR_19668381_ChIP-Seq_PC3_Human | 1.48070158 |
| 49 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.47471865 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.46837049 |
| 51 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.45082883 |
| 52 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.44649901 |
| 53 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.43219816 |
| 54 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41309464 |
| 55 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.40528937 |
| 56 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.39268667 |
| 57 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36802496 |
| 58 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.35338272 |
| 59 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.34846526 |
| 60 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.34254135 |
| 61 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.34009395 |
| 62 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.33347509 |
| 63 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.32892896 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.32409023 |
| 65 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.30974435 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.30974435 |
| 67 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.30711477 |
| 68 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29404808 |
| 69 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.28975529 |
| 70 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.28632033 |
| 71 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.28343902 |
| 72 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.27999069 |
| 73 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.27965423 |
| 74 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.27901443 |
| 75 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.27885315 |
| 76 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.27135632 |
| 77 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.26182603 |
| 78 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.25709030 |
| 79 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25325468 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.23952155 |
| 81 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.23901544 |
| 82 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.23519339 |
| 83 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.22976296 |
| 84 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.22813485 |
| 85 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.22768433 |
| 86 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.22750218 |
| 87 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.22479104 |
| 88 | * P68_20966046_ChIP-Seq_HELA_Human | 1.17645416 |
| 89 | TBL1_22424771_ChIP-Seq_293T_Human | 1.15439939 |
| 90 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13630988 |
| 91 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12895854 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.12514217 |
| 93 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.12410933 |
| 94 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.12236161 |
| 95 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11278147 |
| 96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.10158968 |
| 97 | NCOR_22424771_ChIP-Seq_293T_Human | 1.10119929 |
| 98 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09049734 |
| 99 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.07128694 |
| 100 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.06875666 |
| 101 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06630764 |
| 102 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.06230513 |
| 103 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05925529 |
| 104 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05688907 |
| 105 | CBP_21632823_ChIP-Seq_H3396_Human | 1.04539849 |
| 106 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 1.04130015 |
| 107 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.04009868 |
| 108 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03717668 |
| 109 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.03556035 |
| 110 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.03427734 |
| 111 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.02395551 |
| 112 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02393363 |
| 113 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.01285898 |
| 114 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.00973818 |
| 115 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00136102 |
| 116 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.99519227 |
| 117 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.99355103 |
| 118 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.99143566 |
| 119 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.99094310 |
| 120 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.98514056 |
| 121 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98428293 |
| 122 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.97816370 |
| 123 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97686530 |
| 124 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.97068473 |
| 125 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.96874877 |
| 126 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96254994 |
| 127 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.96077057 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95317080 |
| 129 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.95301403 |
| 130 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.94580098 |
| 131 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94375071 |
| 132 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.93950725 |
| 133 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93479878 |
| 134 | STAT3_23295773_ChIP-Seq_U87_Human | 0.92832967 |
| 135 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92412429 |
| 136 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.91639746 |
| 137 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.91326618 |
| 138 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.90419416 |
| 139 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90357137 |
| 140 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89909461 |
| 141 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.89883368 |
| 142 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.89863076 |
| 143 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 0.89365117 |
| 144 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.89308538 |
| 145 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.88717811 |
| 146 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.88663547 |
| 147 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.88658664 |
| 148 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88657587 |
| 149 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.87424310 |
| 150 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.87323323 |
| 151 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.87185774 |
| 152 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.85231582 |
| 153 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.83070564 |
| 154 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.83002025 |
| 155 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.82339463 |
| 156 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.82314521 |
| 157 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81809427 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0005551_abnormal_eye_electrophysiolog | 9.69028478 |
| 2 | MP0005253_abnormal_eye_physiology | 6.94731505 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 6.72151913 |
| 4 | MP0003950_abnormal_plasma_membrane | 4.10005196 |
| 5 | * MP0005195_abnormal_posterior_eye | 3.90058611 |
| 6 | MP0001324_abnormal_eye_pigmentation | 3.54224575 |
| 7 | MP0005391_vision/eye_phenotype | 3.38803274 |
| 8 | MP0002638_abnormal_pupillary_reflex | 3.13480252 |
| 9 | MP0002090_abnormal_vision | 2.86896474 |
| 10 | MP0003329_amyloid_beta_deposits | 2.70330817 |
| 11 | MP0003690_abnormal_glial_cell | 2.69846183 |
| 12 | MP0002229_neurodegeneration | 2.59430348 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.58355917 |
| 14 | MP0000920_abnormal_myelination | 2.50477404 |
| 15 | MP0005167_abnormal_blood-brain_barrier | 2.31577364 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.23201754 |
| 17 | MP0001986_abnormal_taste_sensitivity | 2.23199543 |
| 18 | MP0001764_abnormal_homeostasis | 2.04851948 |
| 19 | MP0003011_delayed_dark_adaptation | 10.4442165 |
| 20 | MP0005670_abnormal_white_adipose | 1.96621459 |
| 21 | MP0002752_abnormal_somatic_nervous | 1.96338965 |
| 22 | MP0003879_abnormal_hair_cell | 1.95643281 |
| 23 | MP0002736_abnormal_nociception_after | 1.80635235 |
| 24 | MP0005058_abnormal_lysosome_morphology | 1.78897370 |
| 25 | MP0002735_abnormal_chemical_nociception | 1.77628814 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.74873354 |
| 27 | MP0002653_abnormal_ependyma_morphology | 1.64322206 |
| 28 | MP0000604_amyloidosis | 1.60626192 |
| 29 | MP0003075_altered_response_to | 1.60619647 |
| 30 | MP0001970_abnormal_pain_threshold | 1.55659607 |
| 31 | MP0003631_nervous_system_phenotype | 1.51678104 |
| 32 | MP0001905_abnormal_dopamine_level | 1.48437325 |
| 33 | MP0002882_abnormal_neuron_morphology | 1.39268701 |
| 34 | MP0002733_abnormal_thermal_nociception | 1.35423843 |
| 35 | MP0001502_abnormal_circadian_rhythm | 1.35072700 |
| 36 | MP0009840_abnormal_foam_cell | 1.31958434 |
| 37 | MP0003123_paternal_imprinting | 1.27758843 |
| 38 | MP0005623_abnormal_meninges_morphology | 1.27373166 |
| 39 | MP0001984_abnormal_olfaction | 1.25237971 |
| 40 | MP0004233_abnormal_muscle_weight | 1.22805510 |
| 41 | MP0001346_abnormal_lacrimal_gland | 1.19172427 |
| 42 | MP0000566_synostosis | 1.15785645 |
| 43 | MP0002295_abnormal_pulmonary_circulatio | 1.14121312 |
| 44 | MP0004019_abnormal_vitamin_homeostasis | 1.12455306 |
| 45 | MP0003183_abnormal_peptide_metabolism | 1.11452693 |
| 46 | MP0000778_abnormal_nervous_system | 1.11122277 |
| 47 | MP0005377_hearing/vestibular/ear_phenot | 1.06987724 |
| 48 | MP0003878_abnormal_ear_physiology | 1.06987724 |
| 49 | MP0005197_abnormal_uvea_morphology | 1.06730178 |
| 50 | MP0001440_abnormal_grooming_behavior | 1.06174444 |
| 51 | MP0004885_abnormal_endolymph | 1.04295323 |
| 52 | MP0001501_abnormal_sleep_pattern | 1.01747555 |
| 53 | MP0002249_abnormal_larynx_morphology | 1.01515683 |
| 54 | MP0004185_abnormal_adipocyte_glucose | 1.01450332 |
| 55 | MP0002127_abnormal_cardiovascular_syste | 0.98776057 |
| 56 | MP0005499_abnormal_olfactory_system | 0.98186244 |
| 57 | MP0005394_taste/olfaction_phenotype | 0.98186244 |
| 58 | MP0000747_muscle_weakness | 0.97054620 |
| 59 | MP0008874_decreased_physiological_sensi | 0.95698791 |
| 60 | MP0006292_abnormal_olfactory_placode | 0.92233681 |
| 61 | MP0000955_abnormal_spinal_cord | 0.91818734 |
| 62 | MP0005187_abnormal_penis_morphology | 0.91485484 |
| 63 | MP0002332_abnormal_exercise_endurance | 0.91244297 |
| 64 | MP0008789_abnormal_olfactory_epithelium | 0.90024040 |
| 65 | MP0005171_absent_coat_pigmentation | 0.88336353 |
| 66 | MP0003634_abnormal_glial_cell | 0.85159394 |
| 67 | MP0001958_emphysema | 0.84989720 |
| 68 | MP0002557_abnormal_social/conspecific_i | 0.82480468 |
| 69 | MP0002877_abnormal_melanocyte_morpholog | 0.81348665 |
| 70 | MP0000534_abnormal_ureter_morphology | 0.79886262 |
| 71 | MP0002272_abnormal_nervous_system | 0.75905730 |
| 72 | MP0004270_analgesia | 0.72616195 |
| 73 | MP0005166_decreased_susceptibility_to | 0.68821619 |
| 74 | MP0001486_abnormal_startle_reflex | 0.66267638 |
| 75 | MP0009250_abnormal_appendicular_skeleto | 0.64110247 |
| 76 | MP0004147_increased_porphyrin_level | 0.62696581 |
| 77 | MP0001177_atelectasis | 0.61162151 |
| 78 | MP0004215_abnormal_myocardial_fiber | 0.61109960 |
| 79 | MP0000762_abnormal_tongue_morphology | 0.60567067 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 0.60230030 |
| 81 | MP0000681_abnormal_thyroid_gland | 0.60098903 |
| 82 | MP0001348_abnormal_lacrimal_gland | 0.59313919 |
| 83 | MP0005666_abnormal_adipose_tissue | 0.58714144 |
| 84 | MP0005535_abnormal_body_temperature | 0.57100044 |
| 85 | MP0002734_abnormal_mechanical_nocicepti | 0.54025710 |
| 86 | MP0003279_aneurysm | 0.53988357 |
| 87 | MP0001286_abnormal_eye_development | 0.53129102 |
| 88 | MP0005503_abnormal_tendon_morphology | 0.52653954 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.50218044 |
| 90 | MP0003880_abnormal_central_pattern | 0.49548949 |
| 91 | MP0003646_muscle_fatigue | 0.46510824 |
| 92 | MP0002064_seizures | 0.46205502 |
| 93 | MP0000751_myopathy | 0.45508986 |
| 94 | MP0005376_homeostasis/metabolism_phenot | 0.45345454 |
| 95 | MP0009046_muscle_twitch | 0.45051247 |
| 96 | MP0004782_abnormal_surfactant_physiolog | 0.44839749 |
| 97 | MP0003635_abnormal_synaptic_transmissio | 0.43099817 |
| 98 | MP0001963_abnormal_hearing_physiology | 0.42790398 |
| 99 | MP0005620_abnormal_muscle_contractility | 0.42252594 |
| 100 | MP0004859_abnormal_synaptic_plasticity | 0.41236453 |
| 101 | MP0002067_abnormal_sensory_capabilities | 0.41206961 |
| 102 | MP0003045_fibrosis | 0.40456608 |
| 103 | MP0000465_gastrointestinal_hemorrhage | 0.40442523 |
| 104 | MP0004085_abnormal_heartbeat | 0.39869234 |
| 105 | MP0010386_abnormal_urinary_bladder | 0.39493051 |
| 106 | MP0005248_abnormal_Harderian_gland | 0.39225363 |
| 107 | MP0004036_abnormal_muscle_relaxation | 0.38324138 |
| 108 | MP0004043_abnormal_pH_regulation | 0.37900515 |
| 109 | MP0004084_abnormal_cardiac_muscle | 0.36741524 |
| 110 | MP0005595_abnormal_vascular_smooth | 0.35024302 |
| 111 | MP0002063_abnormal_learning/memory/cond | 0.33721654 |
| 112 | MP0002697_abnormal_eye_size | 0.33685975 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 0.31161041 |
| 114 | MP0005386_behavior/neurological_phenoty | 0.30278778 |
| 115 | MP0004924_abnormal_behavior | 0.30278778 |
| 116 | MP0002572_abnormal_emotion/affect_behav | 0.29334949 |
| 117 | MP0005193_abnormal_anterior_eye | 0.28743576 |
| 118 | MP0002234_abnormal_pharynx_morphology | 0.28276176 |
| 119 | MP0005076_abnormal_cell_differentiation | 0.27439112 |
| 120 | MP0010030_abnormal_orbit_morphology | 0.27403618 |
| 121 | MP0009745_abnormal_behavioral_response | 0.26064484 |
| 122 | MP0008569_lethality_at_weaning | 0.25893279 |
| 123 | MP0005330_cardiomyopathy | 0.25407382 |
| 124 | MP0008775_abnormal_heart_ventricle | 0.24350913 |
| 125 | MP0004142_abnormal_muscle_tone | 0.24305688 |
| 126 | MP0002184_abnormal_innervation | 0.24052006 |
| 127 | MP0000749_muscle_degeneration | 0.23214285 |
| 128 | MP0004811_abnormal_neuron_physiology | 0.22498584 |
| 129 | MP0001968_abnormal_touch/_nociception | 0.22463784 |
| 130 | MP0001661_extended_life_span | 0.22049652 |
| 131 | MP0000026_abnormal_inner_ear | 0.21522465 |
| 132 | MP0003890_abnormal_embryonic-extraembry | 0.21431092 |
| 133 | MP0002152_abnormal_brain_morphology | 0.21029651 |
| 134 | MP0002108_abnormal_muscle_morphology | 0.20635402 |
| 135 | MP0002066_abnormal_motor_capabilities/c | 0.19964466 |
| 136 | MP0003252_abnormal_bile_duct | 0.19816677 |
| 137 | MP0004742_abnormal_vestibular_system | 0.19539009 |
| 138 | MP0001915_intracranial_hemorrhage | 0.19232514 |
| 139 | MP0002909_abnormal_adrenal_gland | 0.19113758 |
| 140 | MP0009780_abnormal_chondrocyte_physiolo | 0.18600390 |
| 141 | MP0003633_abnormal_nervous_system | 0.17249407 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.17123404 |
| 143 | MP0008961_abnormal_basal_metabolism | 0.16998075 |
| 144 | MP0002928_abnormal_bile_duct | 0.16644195 |
| 145 | MP0003137_abnormal_impulse_conducting | 0.16506813 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.16050483 |
| 147 | MP0008004_abnormal_stomach_pH | 0.15174794 |
| 148 | MP0002972_abnormal_cardiac_muscle | 0.14054699 |
| 149 | MP0003632_abnormal_nervous_system | 0.14004740 |
| 150 | MP0004130_abnormal_muscle_cell | 0.13368883 |
| 151 | MP0010368_abnormal_lymphatic_system | 0.13264545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chorioretinal atrophy (HP:0000533) | 9.34658809 |
| 2 | Central scotoma (HP:0000603) | 8.31757439 |
| 3 | Pendular nystagmus (HP:0012043) | 8.07704251 |
| 4 | * Pigmentary retinal degeneration (HP:0001146) | 7.70035172 |
| 5 | Attenuation of retinal blood vessels (HP:0007843) | 7.45193604 |
| 6 | Abnormality of macular pigmentation (HP:0008002) | 7.34379866 |
| 7 | Dyschromatopsia (HP:0007641) | 7.33603206 |
| 8 | Scotoma (HP:0000575) | 7.30831839 |
| 9 | Abolished electroretinogram (ERG) (HP:0000550) | 7.11760755 |
| 10 | Decreased central vision (HP:0007663) | 6.41577954 |
| 11 | * Type II diabetes mellitus (HP:0005978) | 5.62907056 |
| 12 | Action tremor (HP:0002345) | 5.54397856 |
| 13 | * Photophobia (HP:0000613) | 5.45752849 |
| 14 | Keratoconus (HP:0000563) | 5.30694672 |
| 15 | Increased corneal curvature (HP:0100692) | 5.30694672 |
| 16 | Vitreoretinal degeneration (HP:0000655) | 5.20375130 |
| 17 | Macular degeneration (HP:0000608) | 5.11431749 |
| 18 | Posterior subcapsular cataract (HP:0007787) | 4.98097620 |
| 19 | Severe visual impairment (HP:0001141) | 4.97453002 |
| 20 | Cone-rod dystrophy (HP:0000548) | 4.82296597 |
| 21 | Constricted visual fields (HP:0001133) | 4.44205402 |
| 22 | Myokymia (HP:0002411) | 4.39961515 |
| 23 | Choroideremia (HP:0001139) | 4.25643563 |
| 24 | Peripheral hypomyelination (HP:0007182) | 4.20459013 |
| 25 | * Retinitis pigmentosa (HP:0000510) | 4.17382450 |
| 26 | Neurofibrillary tangles (HP:0002185) | 4.05272588 |
| 27 | Abnormality of binocular vision (HP:0011514) | 4.00395184 |
| 28 | Diplopia (HP:0000651) | 4.00395184 |
| 29 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 3.61603936 |
| 30 | Ankle clonus (HP:0011448) | 3.52548582 |
| 31 | Supranuclear gaze palsy (HP:0000605) | 3.47513984 |
| 32 | Progressive visual loss (HP:0000529) | 3.17809746 |
| 33 | Annular pancreas (HP:0001734) | 3.13754810 |
| 34 | Cerebral inclusion bodies (HP:0100314) | 2.99819157 |
| 35 | Subcapsular cataract (HP:0000523) | 2.98057388 |
| 36 | Turricephaly (HP:0000262) | 2.85274337 |
| 37 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.83046155 |
| 38 | Aplasia of the phalanges of the hand (HP:0009802) | 2.83046155 |
| 39 | Aplasia involving bones of the extremities (HP:0009825) | 2.83046155 |
| 40 | Insomnia (HP:0100785) | 2.82065546 |
| 41 | Obstructive sleep apnea (HP:0002870) | 2.75847131 |
| 42 | Retinal atrophy (HP:0001105) | 2.74839544 |
| 43 | Systemic lupus erythematosus (HP:0002725) | 2.72382758 |
| 44 | Optic disc pallor (HP:0000543) | 2.66870237 |
| 45 | Intention tremor (HP:0002080) | 2.61043992 |
| 46 | Focal motor seizures (HP:0011153) | 2.58997188 |
| 47 | Spastic gait (HP:0002064) | 2.58537762 |
| 48 | Cerebral hypomyelination (HP:0006808) | 2.58082489 |
| 49 | Gait imbalance (HP:0002141) | 2.52003997 |
| 50 | Vertebral compression fractures (HP:0002953) | 2.51979713 |
| 51 | Congenital primary aphakia (HP:0007707) | 2.50194198 |
| 52 | * Wide nasal bridge (HP:0000431) | 2.48598245 |
| 53 | Ulnar claw (HP:0001178) | 2.46129474 |
| 54 | Dysmetria (HP:0001310) | 2.44744652 |
| 55 | Hemiparesis (HP:0001269) | 2.41449616 |
| 56 | Axonal loss (HP:0003447) | 2.37194410 |
| 57 | Protrusio acetabuli (HP:0003179) | 2.29138409 |
| 58 | Heterochromia iridis (HP:0001100) | 2.26487309 |
| 59 | Nuclear cataract (HP:0100018) | 2.25202196 |
| 60 | Akinesia (HP:0002304) | 2.24871362 |
| 61 | Nephrogenic diabetes insipidus (HP:0009806) | 2.21463426 |
| 62 | Hyperparathyroidism (HP:0000843) | 2.18580780 |
| 63 | Rigidity (HP:0002063) | 2.18349787 |
| 64 | Scanning speech (HP:0002168) | 2.17451603 |
| 65 | Congenital sensorineural hearing impairment (HP:0008527) | 2.16591664 |
| 66 | Focal seizures (HP:0007359) | 2.14409941 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.11779692 |
| 68 | Biconcave vertebral bodies (HP:0004586) | 2.10509363 |
| 69 | Foot dorsiflexor weakness (HP:0009027) | 2.09715617 |
| 70 | Persistence of primary teeth (HP:0006335) | 2.06664312 |
| 71 | Abnormal eating behavior (HP:0100738) | 2.04384403 |
| 72 | Athetosis (HP:0002305) | 2.02606541 |
| 73 | Congenital stationary night blindness (HP:0007642) | 15.2999712 |
| 74 | Bony spicule pigmentary retinopathy (HP:0007737) | 11.6030633 |
| 75 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 10.9818012 |
| 76 | Abnormal rod and cone electroretinograms (HP:0008323) | 10.7739693 |
| 77 | Clonus (HP:0002169) | 1.96145261 |
| 78 | Spinal canal stenosis (HP:0003416) | 1.95783363 |
| 79 | Congenital glaucoma (HP:0001087) | 1.94845030 |
| 80 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.91955588 |
| 81 | Hyporeflexia of lower limbs (HP:0002600) | 1.91650743 |
| 82 | Rapidly progressive (HP:0003678) | 1.91066601 |
| 83 | Poor coordination (HP:0002370) | 1.90381499 |
| 84 | White forelock (HP:0002211) | 1.89858502 |
| 85 | Torticollis (HP:0000473) | 1.89236496 |
| 86 | Increased CSF protein (HP:0002922) | 1.87757074 |
| 87 | Anxiety (HP:0000739) | 1.86617239 |
| 88 | Dementia (HP:0000726) | 1.86566306 |
| 89 | Slow saccadic eye movements (HP:0000514) | 1.86442442 |
| 90 | Visceral angiomatosis (HP:0100761) | 1.81441494 |
| 91 | Amyloidosis (HP:0011034) | 1.80057444 |
| 92 | Papilledema (HP:0001085) | 1.79542891 |
| 93 | Esophageal varix (HP:0002040) | 1.78423632 |
| 94 | Glomerulonephritis (HP:0000099) | 1.77847465 |
| 95 | Atonic seizures (HP:0010819) | 1.77739635 |
| 96 | Ulnar bowing (HP:0003031) | 1.77638132 |
| 97 | Poor speech (HP:0002465) | 1.77586591 |
| 98 | Increased circulating renin level (HP:0000848) | 1.77542454 |
| 99 | Postural tremor (HP:0002174) | 1.76903537 |
| 100 | Megalencephaly (HP:0001355) | 1.76487255 |
| 101 | Abnormality of the foot musculature (HP:0001436) | 1.76031220 |
| 102 | Urinary incontinence (HP:0000020) | 1.75886263 |
| 103 | Choreoathetosis (HP:0001266) | 1.75578772 |
| 104 | Buphthalmos (HP:0000557) | 1.75188892 |
| 105 | Metaphyseal dysplasia (HP:0100255) | 1.75180074 |
| 106 | Decreased motor nerve conduction velocity (HP:0003431) | 1.72041518 |
| 107 | Abnormality of the periventricular white matter (HP:0002518) | 1.71959607 |
| 108 | Interstitial pulmonary disease (HP:0006530) | 1.70990246 |
| 109 | Shallow orbits (HP:0000586) | 1.70940551 |
| 110 | Vaginal atresia (HP:0000148) | 1.70706665 |
| 111 | Coronal craniosynostosis (HP:0004440) | 1.70541004 |
| 112 | Postural instability (HP:0002172) | 1.69781669 |
| 113 | Delusions (HP:0000746) | 1.69190257 |
| 114 | Complement deficiency (HP:0004431) | 1.68575813 |
| 115 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.68253465 |
| 116 | Abnormality of alanine metabolism (HP:0010916) | 1.68253465 |
| 117 | Hyperalaninemia (HP:0003348) | 1.68253465 |
| 118 | Broad metatarsal (HP:0001783) | 1.67820612 |
| 119 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.67816469 |
| 120 | Hypoplastic left heart (HP:0004383) | 1.65985558 |
| 121 | Mitral regurgitation (HP:0001653) | 1.65146027 |
| 122 | Genital tract atresia (HP:0001827) | 1.63553117 |
| 123 | Polar cataract (HP:0010696) | 1.63434105 |
| 124 | * Optic atrophy (HP:0000648) | 1.62378479 |
| 125 | True hermaphroditism (HP:0010459) | 1.59882799 |
| 126 | Horizontal nystagmus (HP:0000666) | 1.43611243 |
| 127 | Severe Myopia (HP:0011003) | 1.43294056 |
| 128 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.43152429 |
| 129 | Pancreatic fibrosis (HP:0100732) | 1.34073253 |
| 130 | Dysdiadochokinesis (HP:0002075) | 1.31311228 |
| 131 | Abnormality of the fovea (HP:0000493) | 1.25369030 |
| 132 | Hypoplasia of the fovea (HP:0007750) | 1.21301852 |
| 133 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.21301852 |
| 134 | Left ventricular hypertrophy (HP:0001712) | 1.15501381 |
| 135 | Cystic liver disease (HP:0006706) | 1.14722100 |
| 136 | Epileptic encephalopathy (HP:0200134) | 1.12164040 |
| 137 | Astigmatism (HP:0000483) | 1.10034854 |
| 138 | Cerebellar dysplasia (HP:0007033) | 1.09254174 |
| 139 | Retinal detachment (HP:0000541) | 1.08256340 |
| 140 | Pancreatic cysts (HP:0001737) | 1.06016909 |
| 141 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.02248128 |
| 142 | Broad foot (HP:0001769) | 1.01712907 |
| 143 | Sclerocornea (HP:0000647) | 0.99105213 |
| 144 | Recurrent sinusitis (HP:0011108) | 0.99021617 |
| 145 | Aplasia/Hypoplasia of the macula (HP:0008059) | 0.98901255 |
| 146 | Specific learning disability (HP:0001328) | 0.98742650 |
| 147 | Decreased testicular size (HP:0008734) | 0.98251406 |
| 148 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 0.97704888 |
| 149 | Febrile seizures (HP:0002373) | 0.95370294 |
| 150 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 0.92975951 |
| 151 | Asthma (HP:0002099) | 0.92323853 |
| 152 | Visual hallucinations (HP:0002367) | 0.90674012 |
| 153 | Truncal ataxia (HP:0002078) | 0.89902866 |
| 154 | Chorioretinal coloboma (HP:0000567) | 0.87930550 |
| 155 | Hypermetropia (HP:0000540) | 0.85293943 |
| 156 | Progressive cerebellar ataxia (HP:0002073) | 0.85089606 |
| 157 | Prolonged QT interval (HP:0001657) | 0.83035118 |
| 158 | Furrowed tongue (HP:0000221) | 0.82195116 |
| 159 | Partial agenesis of the corpus callosum (HP:0001338) | 0.74273779 |
| 160 | Cholecystitis (HP:0001082) | 0.69712161 |
| 161 | Abnormal gallbladder physiology (HP:0012438) | 0.69712161 |
| 162 | Molar tooth sign on MRI (HP:0002419) | 0.68020462 |
| 163 | Abnormality of midbrain morphology (HP:0002418) | 0.68020462 |
| 164 | Hypodontia (HP:0000668) | 0.67004209 |
| 165 | Abnormality of dental color (HP:0011073) | 0.65976115 |
| 166 | Dental crowding (HP:0000678) | 0.65599153 |
| 167 | Postaxial hand polydactyly (HP:0001162) | 0.65275350 |
| 168 | Congenital hepatic fibrosis (HP:0002612) | 0.65022356 |
| 169 | Septo-optic dysplasia (HP:0100842) | 0.64606883 |
| 170 | Lymphopenia (HP:0001888) | 0.63684731 |
| 171 | Abnormality of the lower motor neuron (HP:0002366) | 0.62796245 |
| 172 | Anencephaly (HP:0002323) | 0.62623479 |
| 173 | Short foot (HP:0001773) | 0.62157865 |
| 174 | Hypoventilation (HP:0002791) | 0.61777449 |
| 175 | Syncope (HP:0001279) | 0.61284762 |
| 176 | Albinism (HP:0001022) | 0.60560661 |
| 177 | Abnormal EKG (HP:0003115) | 0.60341857 |
| 178 | Genetic anticipation (HP:0003743) | 0.59565888 |
| 179 | Hirsutism (HP:0001007) | 0.58770686 |
| 180 | Polycystic ovaries (HP:0000147) | 0.58520637 |
| 181 | Depression (HP:0000716) | 0.58223597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK1 | 9.77991911 |
| 2 | PBK | 7.74731876 |
| 3 | PINK1 | 3.08688881 |
| 4 | IRAK2 | 3.02484338 |
| 5 | NTRK3 | 3.00640757 |
| 6 | TESK2 | 2.94564770 |
| 7 | NTRK2 | 2.85900880 |
| 8 | UHMK1 | 2.42569081 |
| 9 | EPHA4 | 2.36062018 |
| 10 | MAP3K10 | 2.23848798 |
| 11 | NTRK1 | 2.05610020 |
| 12 | CAMK2B | 2.02915623 |
| 13 | TESK1 | 1.96558698 |
| 14 | INSRR | 1.92933042 |
| 15 | CAMK2G | 1.82369370 |
| 16 | MAP3K11 | 1.80901751 |
| 17 | TRIB3 | 1.71013707 |
| 18 | DAPK2 | 1.69687048 |
| 19 | NEK1 | 1.65454557 |
| 20 | CCNB1 | 1.64806736 |
| 21 | ERN1 | 1.63868387 |
| 22 | SIK2 | 1.60617958 |
| 23 | ICK | 1.58385168 |
| 24 | TYRO3 | 1.54099043 |
| 25 | ADRBK1 | 1.53209964 |
| 26 | CAMK1G | 1.52306999 |
| 27 | MAP2K3 | 1.52062639 |
| 28 | SGK494 | 1.47088457 |
| 29 | SGK223 | 1.47088457 |
| 30 | MAPK7 | 1.45728480 |
| 31 | ARAF | 1.40378214 |
| 32 | RPS6KA4 | 1.39079433 |
| 33 | CAMK1D | 1.38705911 |
| 34 | TAOK3 | 1.37126349 |
| 35 | PRKD3 | 1.32949740 |
| 36 | PAK6 | 1.28716009 |
| 37 | MAPK12 | 1.27234023 |
| 38 | MAP3K3 | 1.25686595 |
| 39 | HIPK2 | 1.24249476 |
| 40 | LIMK1 | 1.18243834 |
| 41 | DDR2 | 1.15740825 |
| 42 | TAOK2 | 1.15596153 |
| 43 | STK38 | 1.14010656 |
| 44 | CDK12 | 1.12970090 |
| 45 | MAP3K6 | 1.10815613 |
| 46 | BRD4 | 1.10494812 |
| 47 | PRKCZ | 1.06368006 |
| 48 | EPHB2 | 1.06272047 |
| 49 | PRKCH | 1.04024266 |
| 50 | MARK1 | 1.01862730 |
| 51 | PHKG2 | 0.99725064 |
| 52 | PHKG1 | 0.99725064 |
| 53 | CDK3 | 0.96396698 |
| 54 | ERBB2 | 0.95757134 |
| 55 | ROCK2 | 0.95617967 |
| 56 | CSNK1D | 0.93745924 |
| 57 | MAP3K13 | 0.89823317 |
| 58 | ABL2 | 0.89791438 |
| 59 | PRKAA1 | 0.88816580 |
| 60 | NME2 | 0.87332408 |
| 61 | MAP3K4 | 0.85524078 |
| 62 | SGK2 | 0.84541704 |
| 63 | LATS2 | 0.82599599 |
| 64 | NEK2 | 0.82266346 |
| 65 | CAMKK1 | 0.80161311 |
| 66 | LMTK2 | 0.79771829 |
| 67 | PNCK | 0.79366766 |
| 68 | DYRK1A | 0.79002198 |
| 69 | SGK3 | 0.78850015 |
| 70 | CDK15 | 0.77007831 |
| 71 | DAPK1 | 0.75557545 |
| 72 | CAMK2D | 0.74484713 |
| 73 | MARK2 | 0.74356020 |
| 74 | IRAK3 | 0.73895699 |
| 75 | SCYL2 | 0.73658656 |
| 76 | DYRK1B | 0.71480105 |
| 77 | CDK11A | 0.69883252 |
| 78 | CAMKK2 | 0.69211737 |
| 79 | KSR2 | 0.69082787 |
| 80 | CDK18 | 0.68987316 |
| 81 | PRKG2 | 0.68430020 |
| 82 | PRKACG | 0.67858927 |
| 83 | PTK2 | 0.66906943 |
| 84 | MOS | 0.66643495 |
| 85 | PDGFRA | 0.66282841 |
| 86 | CDK14 | 0.66127208 |
| 87 | SMG1 | 0.65793903 |
| 88 | PRKCB | 0.65531718 |
| 89 | AKT3 | 0.62789829 |
| 90 | WNK1 | 0.62469950 |
| 91 | GRK5 | 0.59883294 |
| 92 | RPS6KA3 | 0.59439935 |
| 93 | PRKD2 | 0.58112340 |
| 94 | DAPK3 | 0.57311056 |
| 95 | SIK1 | 0.56192334 |
| 96 | MYLK | 0.56155195 |
| 97 | ROCK1 | 0.55585904 |
| 98 | PRKAA2 | 0.55115895 |
| 99 | CAMK1 | 0.54128548 |
| 100 | BCKDK | 0.54095718 |
| 101 | DMPK | 0.53519357 |
| 102 | MAP3K7 | 0.52663134 |
| 103 | MAP3K1 | 0.50383686 |
| 104 | CAMK2A | 0.49532622 |
| 105 | CDK9 | 0.49342871 |
| 106 | FES | 0.48561396 |
| 107 | MINK1 | 0.47316621 |
| 108 | MAPK4 | 0.46972214 |
| 109 | MAPK9 | 0.46618085 |
| 110 | LATS1 | 0.46004554 |
| 111 | SGK1 | 0.45182241 |
| 112 | MAPKAPK5 | 0.44343231 |
| 113 | CAMK4 | 0.44164017 |
| 114 | PDPK1 | 0.43498600 |
| 115 | AKT2 | 0.43411068 |
| 116 | GSK3B | 0.42532836 |
| 117 | PIK3CA | 0.42239775 |
| 118 | PRKDC | 0.40876068 |
| 119 | RIPK1 | 0.40515810 |
| 120 | STK11 | 0.39735541 |
| 121 | MAPK14 | 0.39717996 |
| 122 | PRPF4B | 0.39151749 |
| 123 | FGFR2 | 0.38136342 |
| 124 | MAP2K1 | 0.37819891 |
| 125 | MAPK10 | 0.37768580 |
| 126 | CDK5 | 0.36975693 |
| 127 | MAP2K4 | 0.36273073 |
| 128 | PRKACA | 0.35956798 |
| 129 | RPS6KA5 | 0.35446071 |
| 130 | BMX | 0.35423240 |
| 131 | PLK2 | 0.35369598 |
| 132 | PRKCG | 0.34741438 |
| 133 | MAP3K9 | 0.34063425 |
| 134 | NEK6 | 0.32786537 |
| 135 | PDGFRB | 0.31969403 |
| 136 | PLK3 | 0.31063846 |
| 137 | PRKCA | 0.29470471 |
| 138 | CDK1 | 0.29060463 |
| 139 | CDC42BPA | 0.28445365 |
| 140 | PRKD1 | 0.28406498 |
| 141 | TTK | 0.25832068 |
| 142 | PKN1 | 0.25254438 |
| 143 | RPS6KB1 | 0.23552352 |
| 144 | CSNK1E | 0.22824884 |
| 145 | TNK2 | 0.22522517 |
| 146 | PAK3 | 0.21300398 |
| 147 | MAPK8 | 0.21048385 |
| 148 | ALK | 0.21006384 |
| 149 | WNK4 | 0.20665884 |
| 150 | CHEK2 | 0.19085554 |
| 151 | PDK2 | 0.18206756 |
| 152 | TTN | 0.17922226 |
| 153 | FGFR1 | 0.17791979 |
| 154 | MAPK3 | 0.17430560 |
| 155 | MTOR | 0.16164572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 15.7781407 |
| 2 | Prion diseases_Homo sapiens_hsa05020 | 1.78426242 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.74711734 |
| 4 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.66387328 |
| 5 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.51972110 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 1.51695523 |
| 7 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.50191440 |
| 8 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.40210900 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.35481086 |
| 10 | GABAergic synapse_Homo sapiens_hsa04727 | 1.32809696 |
| 11 | Sulfur relay system_Homo sapiens_hsa04122 | 1.28007352 |
| 12 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20793995 |
| 13 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.20715703 |
| 14 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.14259717 |
| 15 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.00320096 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.94828962 |
| 17 | Circadian rhythm_Homo sapiens_hsa04710 | 0.94278851 |
| 18 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92499794 |
| 19 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.92350703 |
| 20 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.91262842 |
| 21 | Glioma_Homo sapiens_hsa05214 | 0.91006801 |
| 22 | Morphine addiction_Homo sapiens_hsa05032 | 0.90575485 |
| 23 | Retinol metabolism_Homo sapiens_hsa00830 | 0.89402045 |
| 24 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86087677 |
| 25 | Melanogenesis_Homo sapiens_hsa04916 | 0.84177852 |
| 26 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81730905 |
| 27 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81727812 |
| 28 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80625182 |
| 29 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80581229 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80551030 |
| 31 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.80062596 |
| 32 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77792289 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.75022871 |
| 34 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74807204 |
| 35 | Gap junction_Homo sapiens_hsa04540 | 0.71025918 |
| 36 | Lysosome_Homo sapiens_hsa04142 | 0.68703025 |
| 37 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.68364167 |
| 38 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.67362244 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67152903 |
| 40 | Insulin secretion_Homo sapiens_hsa04911 | 0.63314946 |
| 41 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.62181767 |
| 42 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.61673356 |
| 43 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.59273120 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 0.58896853 |
| 45 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57526219 |
| 46 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.56588665 |
| 47 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56441345 |
| 48 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.52468163 |
| 49 | Nicotine addiction_Homo sapiens_hsa05033 | 0.50454231 |
| 50 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49953749 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.49939240 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 0.49909026 |
| 53 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.47739448 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47012356 |
| 55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.46747435 |
| 56 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.45385041 |
| 57 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.45118279 |
| 58 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.44334936 |
| 59 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44244968 |
| 60 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.43783518 |
| 61 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.43523661 |
| 62 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41184141 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.40812160 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39697479 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 0.39513769 |
| 66 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.39042470 |
| 67 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38874369 |
| 68 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.38110370 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.37706333 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.37005144 |
| 71 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.36249950 |
| 72 | Purine metabolism_Homo sapiens_hsa00230 | 0.36249087 |
| 73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36236446 |
| 74 | Renin secretion_Homo sapiens_hsa04924 | 0.35664412 |
| 75 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35662014 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.35337974 |
| 77 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.35083396 |
| 78 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34212546 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.34183826 |
| 80 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33462873 |
| 81 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33273913 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.33131005 |
| 83 | Salivary secretion_Homo sapiens_hsa04970 | 0.33109141 |
| 84 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.32315091 |
| 85 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.31499826 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.28560993 |
| 87 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27275073 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.26940906 |
| 89 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.26462596 |
| 90 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.26339708 |
| 91 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.26322551 |
| 92 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.26069604 |
| 93 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.24507040 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.24370373 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23360486 |
| 96 | Alcoholism_Homo sapiens_hsa05034 | 0.23319206 |
| 97 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.22824696 |
| 98 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.22778900 |
| 99 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22001431 |
| 100 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.21285488 |
| 101 | Cocaine addiction_Homo sapiens_hsa05030 | 0.21062348 |
| 102 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.21049478 |
| 103 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20876338 |
| 104 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.20769636 |
| 105 | Bile secretion_Homo sapiens_hsa04976 | 0.19150759 |
| 106 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.18986615 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.18284537 |
| 108 | Long-term potentiation_Homo sapiens_hsa04720 | 0.15043608 |
| 109 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.13814773 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.13691837 |
| 111 | Carbon metabolism_Homo sapiens_hsa01200 | 0.12858560 |
| 112 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.12439484 |
| 113 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.12122991 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.12051990 |
| 115 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.10937784 |
| 116 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.09921906 |
| 117 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.09914715 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.09854096 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.09151903 |
| 120 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.08591028 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.08363141 |
| 122 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.08354467 |
| 123 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.07546115 |
| 124 | Tight junction_Homo sapiens_hsa04530 | 0.07032478 |
| 125 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.06846143 |
| 126 | Taste transduction_Homo sapiens_hsa04742 | 0.06241452 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.06062974 |
| 128 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.05223072 |
| 129 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.05104823 |
| 130 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.04511488 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.04408646 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.03007075 |
| 133 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02664566 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02437594 |
| 135 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.02253560 |
| 136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.02055322 |
| 137 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.01551834 |
| 138 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.01262921 |
| 139 | Endocytosis_Homo sapiens_hsa04144 | 0.01152791 |

